Jianzhijia Pharmaceutical Chain Group Management
Management criteria checks 4/4
We currently do not have sufficient information about the CEO.
Key information
Bo Lan
Chief executive officer
CN¥816.6k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | 22.6% |
| Management average tenure | 3.9yrs |
| Board average tenure | 4yrs |
Recent management updates
Recent updates
Further Upside For Jianzhijia Pharmaceutical Chain Group Co., Ltd. (SHSE:605266) Shares Could Introduce Price Risks After 33% Bounce
Nov 12
We Think Jianzhijia Pharmaceutical Chain Group (SHSE:605266) Is Taking Some Risk With Its Debt
Oct 03What Is Jianzhijia Pharmaceutical Chain Group Co., Ltd.'s (SHSE:605266) Share Price Doing?
Jul 16Investors Don't See Light At End Of Jianzhijia Pharmaceutical Chain Group Co., Ltd.'s (SHSE:605266) Tunnel And Push Stock Down 28%
Jun 19Improved Earnings Required Before Jianzhijia Pharmaceutical Chain Group Co., Ltd. (SHSE:605266) Shares Find Their Feet
Feb 27CEO
Bo Lan (57 yo)
no data
Tenure
CN¥816,600
Compensation
Mr. Bo Lan serves as Chairman of the Board and General Manager at Jianzhijia Pharmaceutical Chain Group Co., Ltd. (formerly known as Yunnan Jianzhijia Health-Chain Co., Ltd.).
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & GM | no data | CN¥816.60k | 22.59% CN¥ 923.4m | |
| CFO, Deputy GM | no data | CN¥464.50k | 0.036% CN¥ 1.5m | |
| Deputy General Manager | 3.9yrs | CN¥502.40k | 0.17% CN¥ 7.0m | |
| Deputy General Manager | 3.9yrs | CN¥818.30k | 0.16% CN¥ 6.5m | |
| Deputy General Manager | 3.9yrs | CN¥254.60k | 0.021% CN¥ 877.1k | |
| Deputy General Manager | 1.7yrs | CN¥400.90k | 0.026% CN¥ 1.1m | |
| Deputy General Manager | 1.7yrs | CN¥399.50k | 0.042% CN¥ 1.7m | |
| Accounting Supervisor | no data | no data | no data |
3.9yrs
Average Tenure
54yo
Average Age
Experienced Management: 605266's management team is considered experienced (3.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & GM | no data | CN¥816.60k | 22.59% CN¥ 923.4m | |
| CFO, Deputy GM | no data | CN¥464.50k | 0.036% CN¥ 1.5m | |
| Chairman of the Supervisory Board | 4yrs | no data | 0.012% CN¥ 479.4k | |
| Independent Director | 4yrs | CN¥120.00k | no data | |
| Supervisor | 4yrs | no data | 0.010% CN¥ 422.6k | |
| Supervisor | 4yrs | no data | 0.0075% CN¥ 306.1k | |
| Director | 4yrs | CN¥120.00k | no data | |
| Director | 4yrs | CN¥120.00k | no data | |
| Independent Director | 4yrs | CN¥120.00k | no data | |
| Independent Director | 4yrs | CN¥120.00k | no data |
4.0yrs
Average Tenure
52.5yo
Average Age
Experienced Board: 605266's board of directors are considered experienced (4 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 11:46 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Jianzhijia Pharmaceutical Chain Group Co., Ltd. is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hao Wu | Chasing Securities |
| Hui Liu | China Galaxy Securities Co., Ltd. |
| Kehan Meng | Haitong International Research Limited |